Skip to main content
. 2023 May 24;44(10):2004–2018. doi: 10.1038/s41401-023-01101-x

Fig. 1. Down regulation of FGF10 in DOXO-induced myocardial injury.

Fig. 1

a Expression of FGF7 subfamily members in doxorubicin-induced myocardial injury determined by qRT-PCR. b Western blotting analysis of FGF10 protein expression in major viscera after doxorubicin injection. c Western blotting analysis of FGF10 protein expression in the mouse heart after doxorubicin injection. d Immunohistochemical staining of FGF10 in cardiac sections. Top row: ×200 magnification. Bottom row: ×400 magnification. e Statistical analysis of Western blotting presented in c. The results are shown as relative gray value. f Statistical analysis of immunohistochemistry in d. The results are shown as positive staining area per total area of the heart (% Area). GAPDH was used as an internal control. DOXO doxorubicin, FGF10 Fibroblast growth factor 10. ns non-significant; *P < 0.05; **P < 0.01; ****P < 0.0001. Scaler bar: 100 μm.